I invest in a select few CDN microcaps with huge potential & downside. Not an IA so always do your own DD! Away from Twitter for months when life demands it.
@grok@hariskhan09988@jacksonhinkle Thank you, Grok! In your opinion, based on all publicity available data, which on the 4, if any, are more likely to have a functional cure available for the public in the next 2 years?
Want a chance to win 1 full bitcoin? Yeah, you do. Repost and reply with #WealthsimpleCrypto and #contest to be entered into our all-time highest giveaway.
@Nature Great news indeed. First it was @SernovaCorp and now others are achieving results that will effectively help cure type 1 diabetes. The future looks bright.
Today we shared new positive data from the Phase I/II #ClinicalTrial of our Cell Pouch Transplant System in #Type1Diabetes (#T1D). Notably, these data show that islets can function and survive within our Cell Pouch for more than 5 years. Learn more: https://t.co/iWBJwKB6E3
@StageZeroLS Have you partnered with or consider partnering with @GuardantHealth for the Aristotle & ColonSentry #cancer tests? James Howard-Tripp should check out https://t.co/6dFgZyo5F9
A glowing article from Insider Financial highlighting Sernova as a "Best in Breed" of companies developing a functional cure for type 1 diabetes. (TSX:SVA/ OTCQC:SEOVF/ FSE/XETRA:PSH)
https://t.co/0v8gcvVKQg
@MeyiToronto@JimChuong The Brookfield/Microsoft $10b renewable energy deal makes me believe this could have something to do with Algonquin which is looking to divest from their renewable business.
@CTVNews It’s time @GovCanHealth & @ONThealth authorizes the use & coverage of blood tests that helps with #earlydetection of #cancer. @StageZeroLS and other in this space needs to step up and have frank open discussions with the government to move this forward.
@Merck Solid performance yet again. Absolutely love the growth in revenues, net income, EPS & my MRK shares!
Hope Rob has some more deals in the works as 2028 is fast approaching. Would be good to see regenerative medicine be a large part of the future portfolio.
@globalnews While it may not be suitable for Mélanie Roussel, there are ‘safe’ options available already for cancer patients to prolong life. Simply look at startups like @COncologyClinic